Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 AUD | 0.00% | -6.15% | +14.02% |
05-15 | Recce Pharmaceuticals Doses First Patient in Urosepsis Rapid Infusion Clinical Trial | MT |
05-10 | Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.02% | 83.16M | |
+33.67% | 709B | |
+30.98% | 595B | |
-2.20% | 367B | |
+20.70% | 334B | |
+5.07% | 289B | |
+14.42% | 239B | |
+9.28% | 211B | |
-3.44% | 203B | |
+8.38% | 171B |
- Stock Market
- Equities
- RCE Stock
- News Recce Pharmaceuticals Ltd
- Recce Pharmaceuticals Advances Production of Anti-Infective Medication